Novonesis

Home
Last Updated:02-27 2023

Company profile

Chr. Hansen and Novozymes have joined forces to create Novonesis, a leading biosolutions partner.Tiny but mighty enzymes, functional proteins and microbes enable change in all living things. We put that transformational power at the core of our biosolutions to help solve some of humanity’s biggest challenges. Operating globally, with over 40 R&D and application centers and 20 production bases, our biosolutions have created value for consumers across 30+ industries, benefiting the planet. Through acquisitions and organic growth, Novonesis Human Health Biosolution has established a global business network, offering an effective and extensive product portfolio in the field of human health, securing a leading position. As part of Novozymes, HHB has access to one of the world’s largest collections of enzymes, bacterial cultures, and bioactives. Combining this immense resource with data analysis, cutting-edge microbiome research, and clinical studies, we delve deep into the trillions of bacteria that live in, on, and around us. From millions of possibilities we select only the most effective bacterial strains to create targeted ‘One-in-a-trillion’ solutions with proven benefits.

Main Sales Markets:North America，Central/South America，Western Europe，Eastern Europe，Australasia，Asia，Middle East，Africa	Registration number:-
Main Competitive Advantages:Brandname	Main Product Categories:Food Raw Materials and Ingredients
All Sales(USD):choose not to disclose	Main Customer Name:

company Snapshot

Year Established:1997
Total Number of Staff: less than 10 person

Business Type：Manufacturer
Main Sales Markets：North America，Central/South America，Western Europe，Eastern Europe，Australasia，Asia，Middle East，Africa

Address:CHINA

Contact:
TEL:86-
Fax:86-

Recommended Suppliers See All >>